Close
Close
Treatment Database
Interferon alfa-2a (recombinant)
Trade Name Roferon-A
Orphan Indication For the treatment of metastatic malignant melanoma in combination with Teceleukin
USA Market Approval
USA Designation Date 11-05-1990
Sponsor Hoffmann-La Roche, Inc.
340 Kingsland Street
Nutley, New Jersey, 07119
More about Metastatic Melanoma
Free Newsletter
Treatment News
Related Videos
by Wally Wagner Bencomo
1,600 views